252 related articles for article (PubMed ID: 12948007)
21. Transport characteristics of tryptanthrin and its inhibitory effect on P-gp and MRP2 in Caco-2 cells.
Zhu X; Zhang X; Ma G; Yan J; Wang H; Yang Q
J Pharm Pharm Sci; 2011; 14(3):325-35. PubMed ID: 21824448
[TBL] [Abstract][Full Text] [Related]
22. Influence of overexpression of efflux proteins on the function and gene expression of endogenous peptide transporters in MDR-transfected MDCKII cell lines.
Wang Z; Pal D; Patel A; Kwatra D; Mitra AK
Int J Pharm; 2013 Jan; 441(1-2):40-9. PubMed ID: 23262422
[TBL] [Abstract][Full Text] [Related]
23. Intestinal human colon adenocarcinoma cell line LS180 is an excellent model to study pregnane X receptor, but not constitutive androstane receptor, mediated CYP3A4 and multidrug resistance transporter 1 induction: studies with anti-human immunodeficiency virus protease inhibitors.
Gupta A; Mugundu GM; Desai PB; Thummel KE; Unadkat JD
Drug Metab Dispos; 2008 Jun; 36(6):1172-80. PubMed ID: 18332086
[TBL] [Abstract][Full Text] [Related]
24. Rifampin and digoxin induction of MDR1 expression and function in human intestinal (T84) epithelial cells.
Haslam IS; Jones K; Coleman T; Simmons NL
Br J Pharmacol; 2008 May; 154(1):246-55. PubMed ID: 18332862
[TBL] [Abstract][Full Text] [Related]
25. Regulation of expression and activity of multidrug resistance proteins MRP2 and MDR1 by estrogenic compounds in Caco-2 cells. Role in prevention of xenobiotic-induced cytotoxicity.
Arias A; Rigalli JP; Villanueva SS; Ruiz ML; Luquita MG; Perdomo VG; Vore M; Catania VA; Mottino AD
Toxicology; 2014 Jun; 320():46-55. PubMed ID: 24685904
[TBL] [Abstract][Full Text] [Related]
26. Comparison of inducibility of multidrug resistance (MDR)1, multidrug resistance-associated protein (MRP)1, and MRP2 mRNAs by prototypical microsomal enzyme inducers in primary cultures of human and cynomolgus monkey hepatocytes.
Nishimura M; Koeda A; Morikawa H; Satoh T; Narimatsu S; Naito S
Biol Pharm Bull; 2008 Nov; 31(11):2068-72. PubMed ID: 18981575
[TBL] [Abstract][Full Text] [Related]
27. Valproic acid induces CYP3A4 and MDR1 gene expression by activation of constitutive androstane receptor and pregnane X receptor pathways.
Cerveny L; Svecova L; Anzenbacherova E; Vrzal R; Staud F; Dvorak Z; Ulrichova J; Anzenbacher P; Pavek P
Drug Metab Dispos; 2007 Jul; 35(7):1032-41. PubMed ID: 17392393
[TBL] [Abstract][Full Text] [Related]
28. Regional Expression Levels of Drug Transporters and Metabolizing Enzymes along the Pig and Human Intestinal Tract and Comparison with Caco-2 Cells.
Vaessen SF; van Lipzig MM; Pieters RH; Krul CA; Wortelboer HM; van de Steeg E
Drug Metab Dispos; 2017 Apr; 45(4):353-360. PubMed ID: 28153842
[TBL] [Abstract][Full Text] [Related]
29. Are MDCK cells transfected with the human MDR1 gene a good model of the human intestinal mucosa?
Tang F; Horie K; Borchardt RT
Pharm Res; 2002 Jun; 19(6):765-72. PubMed ID: 12134945
[TBL] [Abstract][Full Text] [Related]
30. Comparison of the expression and function of ATP binding cassette transporters in Caco-2 and T84 cells on stimulation by selected endogenous compounds and xenobiotics.
Naruhashi K; Kurahashi Y; Fujita Y; Kawakita E; Yamasaki Y; Hattori K; Nishimura A; Shibata N
Drug Metab Pharmacokinet; 2011; 26(2):145-53. PubMed ID: 21127384
[TBL] [Abstract][Full Text] [Related]
31. ABC and SLC transporter expression and proton oligopeptide transporter (POT) mediated permeation across the human blood--brain barrier cell line, hCMEC/D3 [corrected].
Carl SM; Lindley DJ; Das D; Couraud PO; Weksler BB; Romero I; Mowery SA; Knipp GT
Mol Pharm; 2010 Aug; 7(4):1057-68. PubMed ID: 20524699
[TBL] [Abstract][Full Text] [Related]
32. Spatial expression patterns of peptide transporters in the human and rat gastrointestinal tracts, Caco-2 in vitro cell culture model, and multiple human tissues.
Herrera-Ruiz D; Wang Q; Gudmundsson OS; Cook TJ; Smith RL; Faria TN; Knipp GT
AAPS PharmSci; 2001; 3(1):E9. PubMed ID: 11741260
[TBL] [Abstract][Full Text] [Related]
33. P-glycoprotein (P-gp/MDR1)-mediated efflux of sex-steroid hormones and modulation of P-gp expression in vitro.
Kim WY; Benet LZ
Pharm Res; 2004 Jul; 21(7):1284-93. PubMed ID: 15290871
[TBL] [Abstract][Full Text] [Related]
34. Creation of polarized cells coexpressing CYP3A4, NADPH cytochrome P450 reductase and MDR1/P-glycoprotein.
Brimer C; Dalton JT; Zhu Z; Schuetz J; Yasuda K; Vanin E; Relling MV; Lu Y; Schuetz EG
Pharm Res; 2000 Jul; 17(7):803-10. PubMed ID: 10990198
[TBL] [Abstract][Full Text] [Related]
35. Expression and regulation of breast cancer resistance protein and multidrug resistance associated protein 2 in BALB/c mice.
Han Y; Sugiyama Y
Biol Pharm Bull; 2006 May; 29(5):1032-5. PubMed ID: 16651740
[TBL] [Abstract][Full Text] [Related]
36. Analysis of drug transporter expression in human intestinal Caco-2 cells by real-time PCR.
Maubon N; Le Vee M; Fossati L; Audry M; Le Ferrec E; Bolze S; Fardel O
Fundam Clin Pharmacol; 2007 Dec; 21(6):659-63. PubMed ID: 18034668
[TBL] [Abstract][Full Text] [Related]
37. Effects of nonsteroidal anti-inflammatory drugs on the expression and function of P-glycoprotein/MDR1 in Caco-2 cells.
Takara K; Hayashi R; Kokufu M; Yamamoto K; Kitada N; Ohnishi N; Yokoyama T
Drug Chem Toxicol; 2009; 32(4):332-7. PubMed ID: 19793025
[TBL] [Abstract][Full Text] [Related]
38. Contribution of cholesterol and phospholipids to inhibitory effect of dimethyl-beta-cyclodextrin on efflux function of P-glycoprotein and multidrug resistance-associated protein 2 in vinblastine-resistant Caco-2 cell monolayers.
Arima H; Yunomae K; Morikawa T; Hirayama F; Uekama K
Pharm Res; 2004 Apr; 21(4):625-34. PubMed ID: 15139519
[TBL] [Abstract][Full Text] [Related]
39. Enhancement effect of resveratrol on the intestinal absorption of bestatin by regulating PEPT1, MDR1 and MRP2 in vivo and in vitro.
Jia Y; Liu Z; Huo X; Wang C; Meng Q; Liu Q; Sun H; Sun P; Yang X; Shu X; Liu K
Int J Pharm; 2015 Nov; 495(1):588-598. PubMed ID: 26394120
[TBL] [Abstract][Full Text] [Related]
40. Regulation of biliary drug efflux pump expression by hormones and xenobiotics.
Fardel O; Payen L; Courtois A; Vernhet L; Lecureur V
Toxicology; 2001 Oct; 167(1):37-46. PubMed ID: 11557128
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
